Release and stability testing programs for a novel virus-like particle vaccine: release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine

Release and stability testing programs for a novel virus-like particle vaccine: release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biopharm international 2010-10, Vol.23 (10), p.S26
Hauptverfasser: Pincus, Steven, Boddapati, Sarathi, Li, Jingning, Sadowski, Travis
Format: Magazinearticle
Sprache:eng
Schlagworte:
Antigens
Avian influenza
Bacterial infections
Chemical tests and reagents
Contamination
Enzyme-linked immunosorbent assay
Health aspects
Immunotherapy
Influenza vaccines
Lectins
Medical research
Medicine, Experimental
Monoclonal antibodies
Papillomavirus infections
Pharmaceutical industry
Prevention
RNA
Smallpox vaccine
Viral proteins
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1542-166X